Participation in AACR2026: Poster presentation of our phosphorylation analysis results and assistance with exhibition booth for our phosphorylation analysis service

SOCIUM Inc. (https://socium.co.jp/) will present a poster at the AACR (American Association for Cancer Research) Annual Meeting 2026 (San Diego, April 17–23, https://www.aacr.org/meeting/aacr-annual-meeting-2026/) as part of our U.S. promotional campaign for our phosphorylation array analysis services. The presentation will be given by our CEO, Katsuhisa Horimoto (Poster No. 326, April 19, 2:00 PM–5:00 PM). The abstract was published in a special issue of Cancer Research on April 3 (https://doi.org/10.1158/1538-7445.AM2026-326). The presentation will focus on five approved ALK inhibitors—a class of anticancer drugs—and will examine the phosphorylation states responsible for their respective side effects, as well as the identification of off-target kinases. This is a challenging research topic that explores the relationship between side effects at the individual level and kinase activity at the molecular level. The theme of this research was inspired by Professor Hiroshi Kagami of the Department of Respiratory Medicine at Saitama Medical University, where our CEO also serves as a visiting professor.

At the same time, CANON Virginia, Inc., which has provided us with tremendous support for our phosphorylation analysis services in the U.S., will be exhibiting a booth showcasing our services (Booth No. 1448, https://aacr26.mapyourshow.com/8_0/exhibitor/exhibitor-details.cfm?exhid=3859260). We invite anyone planning to attend to please stop by.

We hope this will serve as an opportunity to further advance our phosphorylation array analysis services in the United States.

# To request our phosphorylation analysis services, please use the “CONTACT” section on our website.